Opportunity Information: Apply for RFA AG 24 037
This funding opportunity (RFA-AG-24-037) from the National Institutes of Health uses a cooperative agreement mechanism (U01; clinical trial not allowed) to support the continued operation of two major national longitudinal studies: the National Health and Aging Trends Study (NHATS) and the National Study of Caregiving (NSOC). The core purpose is to keep these studies running by continuing data collection, ongoing development of study content and methods, and broad dissemination of the resulting data resources so researchers can use them to understand aging, disability, and caregiving in the United States. A key emphasis of this competition is to strengthen and expand the ability of NHATS and NSOC to support research on Alzheimer's disease (AD) and AD-related dementias (ADRD), particularly in ways that connect disability trajectories, cognitive decline, and the lived experience of care.
This is a limited competition because the work cannot be done without direct access to the existing NHATS and NSOC sample frames. The awardee must be able to reach the current panel of participants for longitudinal follow-up, which requires personally identifiable information and the operational ability to contact respondents for new interviews and related data collection. Because of that, applicants must provide a formal institutional Letter of Support confirming they have access to the personally identifiable information for NHATS and NSOC panel members and can carry out participant contact for continued follow-up as well as linkages to administrative or program data. In practice, this requirement sharply narrows eligibility to teams already positioned to continue the established NHATS/NSOC infrastructure and relationships.
Programmatically, the solicitation supports a single integrated award that combines NHATS and NSOC under one coordinated project. The intent is to preserve the core elements that make these studies valuable and comparable over time, while also implementing recommendations from the NHATS Data Monitoring Committee to modernize and expand content. The planned enhancements include stronger cognitive and dementia measurement (to better characterize impairment, dementia status, and changes over time), new sensory measures (recognizing the importance of vision and hearing to functioning and dementia risk), and richer dementia care measures (capturing what care looks like, who provides it, and what needs are being met or unmet). The opportunity also calls for adding life-course measures designed to identify and explain sources of health disparities, which supports analyses of how long-run social, economic, and environmental exposures shape late-life health and dementia outcomes. Additional improvements target better residential care data (so transitions into settings such as assisted living or other supportive housing are captured more accurately) and an expanded accelerometry sample to increase objective measurement of movement and activity patterns, which are increasingly relevant to AD/ADRD-related research and to NIA dementia care priorities and milestones.
From an administrative standpoint, this is a discretionary NIH funding opportunity in the health activity category (CFDA 93.866). The closing date listed is September 29, 2023, and the notice does not specify an award ceiling or the expected number of awards in the excerpt provided, although it clearly indicates an intent for a single integrated award for NHATS and NSOC. The cooperative agreement structure signals that NIH will have substantial involvement in the project, which is typical for large, complex national data-collection efforts where the funder may coordinate on priorities, deliverables, and oversight.
Eligibility is broadly described in the standard NIH categories (state and local governments, eligible federal agencies, public and private institutions of higher education, nonprofits with or without 501(c)(3) status, for-profit organizations other than small businesses, small businesses, tribal governments and organizations, and certain housing authorities), and it explicitly highlights categories such as HBCUs, Hispanic-serving institutions, AANAPISISs, tribal colleges and universities, Alaska Native and Native Hawaiian serving institutions, faith-based and community-based organizations, regional organizations, and U.S. territories or possessions. However, the practical gatekeeper is the requirement for access to the NHATS/NSOC sample frame and the ability to contact participants. Foreign organizations and foreign institutions are not eligible to apply, foreign components are not allowed, and non-U.S. components of U.S. organizations are not eligible, aligning with the requirement to manage a U.S.-based national panel and its associated privacy and operational constraints.
Overall, the opportunity is designed to protect the continuity and scientific value of NHATS and NSOC while expanding their usefulness for disability and AD/ADRD research. It prioritizes maintaining longitudinal integrity, improving measurement in areas central to dementia and caregiving, and enhancing the dataset so it can better support research on disparities, care environments, and objective functional indicators, while keeping control of the sample and participant contact within a qualified, already-positioned team.Apply for RFA AG 24 037
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: National Health and Aging Trends (NHATS) and National Study of Caregiving (NSOC) (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2023-06-09.
- Applicants must submit their applications by 2023-09-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs) - NIH RFA-AG-24-037 (NHATS/NSOC)
What is RFA-AG-24-037 funding?
RFA-AG-24-037 is a National Institutes of Health (NIH) funding opportunity that uses a cooperative agreement mechanism (U01; clinical trial not allowed) to support the continued operation of two national longitudinal studies: the National Health and Aging Trends Study (NHATS) and the National Study of Caregiving (NSOC).
What is the main purpose of this opportunity?
The core purpose is to keep NHATS and NSOC operating by continuing data collection, advancing and modernizing study content and methods, and broadly disseminating resulting data resources so researchers can use them to study aging, disability, and caregiving in the United States.
Which studies are included, and how are they structured under this award?
This solicitation supports a single integrated award that combines NHATS and NSOC under one coordinated project, with the intent to preserve the core study elements that make the data valuable and comparable over time.
Is this a grant or a cooperative agreement?
It is a cooperative agreement (U01). This structure indicates NIH will have substantial involvement in the project, which is typical for large, complex national data-collection efforts involving coordinated priorities, deliverables, and oversight.
Are clinical trials allowed under this opportunity?
No. The mechanism is specified as U01; clinical trial not allowed.
Why is this described as a limited competition?
The work cannot be done without direct access to the existing NHATS and NSOC sample frames. The awardee must be able to reach the current panel of participants for longitudinal follow-up, which requires personally identifiable information and the operational ability to contact respondents for new interviews and related data collection.
What makes an applicant practically eligible to apply?
Although eligibility is listed across standard NIH applicant categories, the practical gatekeeper is whether the applicant has access to the NHATS/NSOC sample frame and can conduct participant contact for ongoing longitudinal follow-up. This sharply narrows eligibility to teams already positioned to continue the established NHATS/NSOC infrastructure and relationships.
What documentation is required to demonstrate access to the NHATS/NSOC panel?
Applicants must provide a formal institutional Letter of Support confirming they have access to the personally identifiable information (PII) for NHATS and NSOC panel members and can carry out participant contact for continued follow-up, as well as linkages to administrative or program data.
What kinds of activities does the funding support?
The opportunity supports continued data collection, ongoing development of study content and methods, and broad dissemination of the NHATS and NSOC data resources for research use.
What is the emphasis related to Alzheimer's disease and related dementias?
A key emphasis is strengthening and expanding NHATS and NSOC to better support research on Alzheimer's disease (AD) and AD-related dementias (ADRD), particularly by connecting disability trajectories, cognitive decline, and the lived experience of care.
What enhancements are planned for cognitive and dementia measurement?
The solicitation calls for stronger cognitive and dementia measurement to better characterize impairment, dementia status, and changes over time.
What new sensory measures are being emphasized, and why?
New sensory measures are planned, recognizing the importance of vision and hearing to functioning and dementia risk.
What does the opportunity say about dementia care measurement?
It calls for richer dementia care measures to capture what care looks like, who provides it, and what needs are being met or unmet.
Are health disparities and life-course factors part of the planned improvements?
Yes. The opportunity calls for adding life-course measures designed to identify and explain sources of health disparities, supporting analyses of how long-run social, economic, and environmental exposures shape late-life health and dementia outcomes.
What improvements are planned for residential care measurement?
Additional improvements target better residential care data so transitions into settings such as assisted living or other supportive housing are captured more accurately.
What is the accelerometry component mentioned in the opportunity?
The solicitation calls for an expanded accelerometry sample to increase objective measurement of movement and activity patterns, which are increasingly relevant to AD/ADRD research and to NIA dementia care priorities and milestones.
What is meant by maintaining "longitudinal integrity" and comparability over time?
The intent is to preserve the core elements that make NHATS and NSOC valuable and comparable over time while modernizing and expanding content. In practice, this means continuing follow-up with the existing participant panel and retaining continuity in key measures even as enhancements are added.
How will NIH be involved in the project?
Because this is a cooperative agreement, NIH is expected to have substantial involvement, which commonly includes coordination on priorities, deliverables, and oversight for major national studies.
What is the CFDA number and activity category?
The opportunity is listed as a discretionary NIH funding opportunity in the health activity category, CFDA 93.866.
What is the application closing date listed in the provided information?
The closing date listed is September 29, 2023.
How many awards does NIH expect to make?
The excerpt provided does not specify the expected number of awards, but it clearly indicates an intent for a single integrated award for NHATS and NSOC.
Is there an award ceiling stated in the provided excerpt?
No. The excerpt provided does not specify an award ceiling.
Who is eligible to apply (as described in the opportunity)?
Eligibility is broadly described across standard NIH categories, including state and local governments, eligible federal agencies, public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations other than small businesses, small businesses, tribal governments and organizations, and certain housing authorities. The notice also explicitly highlights HBCUs, Hispanic-serving institutions, AANAPISISs, tribal colleges and universities, Alaska Native and Native Hawaiian serving institutions, faith-based and community-based organizations, regional organizations, and U.S. territories or possessions.
Are foreign organizations eligible to apply?
No. Foreign organizations and foreign institutions are not eligible to apply.
Are foreign components allowed?
No. Foreign components are not allowed, and non-U.S. components of U.S. organizations are not eligible.
Why do the eligibility restrictions emphasize U.S.-based operations?
The restrictions align with the requirement to manage a U.S.-based national longitudinal panel, including privacy constraints around personally identifiable information and the operational need to contact respondents for continued follow-up.
What are the core deliverables implied by this opportunity?
Based on the provided information, the implied deliverables include continued longitudinal data collection for NHATS and NSOC, implementation of content/method enhancements (including AD/ADRD-relevant measures), and broad dissemination of resulting data resources to the research community.
What role do the NHATS Data Monitoring Committee recommendations play?
The intent includes implementing recommendations from the NHATS Data Monitoring Committee to modernize and expand content while preserving key elements for continuity and comparability.
Does this opportunity support linking NHATS/NSOC to administrative or program data?
Yes. The required Letter of Support must confirm the applicant can carry out linkages to administrative or program data (in addition to participant contact for longitudinal follow-up).
What types of research questions is this opportunity designed to enable?
It is designed to support research on aging, disability, and caregiving in the U.S., with a strengthened focus on AD/ADRD, including how disability trajectories relate to cognitive decline and how caregiving is experienced in real-world contexts. It also supports analyses of disparities using life-course measures and objective functional indicators such as accelerometry.
Browse more opportunities from the same category: Health
Next opportunity: USAID Host and Impacted Community Resilience Activity (HICRA)
Previous opportunity: Draft Notice of Funding Opportunity - Children, Adolescents, and Families in the HIV Epidemic in Free State Province
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 24 037
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 24 037) also looked into and applied for these:
| Funding Opportunity |
|---|
| NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) Apply for PAR 23 197 Funding Number: PAR 23 197 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Software for Data Science in Infectious and Immune-Mediated Diseases Research (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 038 Funding Number: RFA AI 23 038 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Development and Characterization of Experimental models of post-TBI ADRD (R01 - Clinical Trial Not Allowed) Apply for PAR 23 218 Funding Number: PAR 23 218 Agency: National Institutes of Health Category: Health Funding Amount: $670,000 |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 24 047 Funding Number: RFA AG 24 047 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) Apply for PAR 23 208 Funding Number: PAR 23 208 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) Apply for PAR 23 207 Funding Number: PAR 23 207 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Interactive Digital Media (IDM) Biomedical Science Resources for Pre-College Students and Teachers (SBIR) (R43/R44 Clinical Trial Not Allowed) Apply for PAR 23 213 Funding Number: PAR 23 213 Agency: National Institutes of Health Category: Health Funding Amount: $295,924 |
| Limited Competition: Human Pangenome Coordinating Center (U41) Clinical Trial Not Allowed Apply for RFA HG 23 025 Funding Number: RFA HG 23 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: High Quality Reference Genomes (UM1 Clinical Trial Not Allowed) Apply for RFA HG 23 024 Funding Number: RFA HG 23 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) Apply for PAR 24 210 Funding Number: PAR 24 210 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) Apply for RFA HG 23 026 Funding Number: RFA HG 23 026 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Simultaneous and Synergistic Multi-Target Validation for Alzheimers Disease-Related Dementias (R61/R33 Clinical Trial not allowed) Apply for PAR 23 195 Funding Number: PAR 23 195 Agency: National Institutes of Health Category: Health Funding Amount: $499,000 |
| Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed) Apply for RFA HG 23 027 Funding Number: RFA HG 23 027 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) Apply for RFA OD 23 019 Funding Number: RFA OD 23 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36) Apply for RFA OD 23 020 Funding Number: RFA OD 23 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) Apply for PAR 23 200 Funding Number: PAR 23 200 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed) Apply for PAR 23 205 Funding Number: PAR 23 205 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed) Apply for RFA NS 24 009 Funding Number: RFA NS 24 009 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Analysis of data in the COVID-19 Neuro Databank-Biobank (R03 - Clinical Trial Not Allowed) Apply for RFA NS 24 025 Funding Number: RFA NS 24 025 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) Apply for PAR 23 225 Funding Number: PAR 23 225 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 24 037", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.